MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss.

MED witnesses revenue plunge as its coach base shrank, but restructuring and productivity initiatives aim to stabilize results by late 2025.

MED targets long-term metabolic health with programs that preserve muscle and support lasting wellness amid GLP-1 adoption.

Medifast (NYSE: MED - Get Free Report) and Vital Farms (NASDAQ: VITL - Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findings based on an online survey conducted by OPTAVIA with KRC Research among a nationally representative group of U.S. adults ages 18–75, recruited to match U.S. Census demographics*. The data highlights a pressing concern: 80% of American adults lack understanding of metabolic health, yet many are e.

BAB (OTCMKTS:BABB - Get Free Report) and Medifast (NYSE: MED - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Profitability This table compares BAB and Medifast's net

Medifast (NYSE: MED - Get Free Report) and Celsius (NASDAQ: CELH - Get Free Report) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership. Institutional and Insider Ownership 95.5% of Medifast shares are

Medifast (NYSE: MED - Get Free Report) and Marzetti (NASDAQ: MZTI - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Dividends Medifast pays an annual dividend of $6.60 per

Acadian Asset Management LLC increased its stake in shares of Medifast Inc (NYSE: MED) by 6.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 411,101 shares of the specialty retailer's stock after purchasing an additional 25,378 shares during the period.

BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basic.